This ASX All Ords share is rocketing 18% following a takeover approach

Superloop has tabled an offer for this cloud communications company.

| More on:
A woman jumps for joy with a rocket drawn on the wall behind her.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Symbio Holdings Ltd (ASX: SYM) share price is rocketing higher on Wednesday.

In morning trade, the ASX All Ords share is up 18% to $2.75.

Why is this ASX All Ords share rocketing?

Investors have been scrambling to buy this cloud communication company's shares after it received a ~$243 million takeover approach from connectivity services provider Superloop Ltd (ASX: SLC).

According to the release, Superloop has tabled an offer that values Symbio at $2.85 per share. This comprises $1.425 cash and 2.14 Superloop shares for each Symbio share.

Symbio shareholders would also be able to elect to receive the proposed purchase price in the form of cash or Superloop shares by way of a mix and match option under the scheme of arrangement. This is subject to scale back to achieve an overall consideration maximum of 50% cash, including any dividends paid.

The release also notes that the indicative proposal contemplates a fully franked dividend to Symbio shareholders prior to scheme implementation of up to $0.35 per share, implying a release of franking credits of up to $0.15 per share.

Including the $0.15 per share from the release of franking credits, the offer increases to $3 per share.

This means that Superloop's offer for the ASX All Ords share is a premium of 19.7% (or 26.1% including franking credits) to its last close price.

Though, it is worth noting that it is still well short of its 52-week high of $4.55. So, this offer could arguably be seen as opportunistic.

What was the response?

The Symbio Board believes that there is sufficient commercial merit in the indicative proposal to enter into the exclusive period for mutual diligence.

However, it notes that it would only progress the indicative proposal on a disciplined basis such that any transaction would be in the best interest of Symbio's shareholders.

It also warned that there is no certainty at this stage that the indicative proposal will progress to a proposal to be considered by Symbio shareholders. In the meantime, shareholders do not need to take any action and the board will update shareholders as appropriate.

Finally, the ASX All Ords share revealed that it is on track to achieve FY 2023 EBITDA at the upper end of its stated guidance. This will be in the range of $27 million to $28 million.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Superloop and Symbio. The Motley Fool Australia has recommended Symbio. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Mergers & Acquisitions

a group of smart looking kids, wearing formal clothes and all with spectacles, sit in a line and smile charmingly.
Mergers & Acquisitions

Takeover bid launched for childcare operator

A takeover bid has been launched for an ASX-listed childcare operator, with its larger rival saying it makes sense to…

Read more »

a woman drawing image on wall of big fish about to eat a small fish
Mergers & Acquisitions

Macquarie names 16 potential ASX takeover targets

The broker thinks these shares could be taken over in the near term.

Read more »

A smiling young woman sits on a bridge in London checking her online shopping, indicating share price movement for ASX BNPL shares overseas.
Mergers & Acquisitions

Hansen just announced a new UK acquisition. So why is the share price falling?

The software provider expands its telco footprint with a UK buyout.

Read more »

Researchers and doctors with futuristic 3d hologram overlay for body anatomy or dna in hospital clinic.
Healthcare Shares

Medibank shares higher on $159m Better Medical acquisition

The private health insurance giant is making a big acquisition.

Read more »

An evening shot of a busy Times Square in New York.
Mergers & Acquisitions

ASX 300 stock tumbles on US expansion plans

An expansion into the United States isn't getting investors excited on Thursday.

Read more »

A woman sits at her home computer with baby on her lap, and the winning ticket in her hand.
Mergers & Acquisitions

Guess which ASX 300 share is jumping 9% on $110m acquisition

Let's see what is getting investors excited on Wednesday.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Mergers & Acquisitions

ASX 300 stock jumps 23% to record high on 'transformational acquisition'

This share is heading to the moon on Tuesday. But why exactly?

Read more »

A man in a suit face palms at the downturn happening with shares today.
Mergers & Acquisitions

Guess which ASX 200 stock is crashing 13% on big news

This stock is being sold off on Thursday. But why?

Read more »